LEXINGTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced results from the special meeting of stockholders on April 11, 2024. T2 Biosystems Stockholders voted for the approval of conversion of $15 million of its term loan with entities affiliated with CRG Servicing LLC (“CRG”) into T2 Biosystems equity. T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
top of page
Suche
Aktuelle Beiträge
Alle ansehenZum Auftakt des 44. Deutschen Psychotherapeutentages (DPT), der am 12. und 13. April in Würzburg stattfindet, richten die Delegierten einen Appell an Bundesgesundheitsminister Prof. Dr. Lauterbach, di
Die Früherkennung von Brustkrebs hat einen entscheidenden Schritt nach vorn gemacht, wie eine neue Publikation aus dem Cordoba Tomosynthesis Screening Trial (CBTST)1 zeigt. Die Forschung konzentrierte
As the world prepares for future and ongoing global health threats from RNA viruses such as the SARS-CoV-2 pandemic, breakthrough advances in antiviral development are becoming a critical weapon in th
bottom of page